Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure

Aims: Pathological left ventricular (LV) remodeling induced by multiple causes often triggers fatal cardiac dysfunction, heart failure (HF), and even cardiac death. This study is aimed to investigate whether qiliqiangxin (QL) could improve LV remodeling and protect against HF via modulating gut micr...

Full description

Bibliographic Details
Main Authors: Yingdong Lu, Mi Xiang, Laiyun Xin, Yang Zhang, Yuling Wang, Zihuan Shen, Li Li, Xiangning Cui
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
gut microbiota
NLRP3 inflammasome
qiliqiangxin
heart failure
ventricular remodeling
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.905424/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.905424/full

Similar Items